Internal Medicine, Nephrology · El Centro, CA
NPI
1346427861
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1550 N Imperial Ave Ste 1
El Centro, CA, 92243
Phone (760) 353-4710
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
69,360 services
Medicare patients, 2024
1,761
Average age 75
Drug cost, 2024
$5.8M
39,950 prescriptions
Company payments, 2025
$610
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohsen M El Ramah was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 7,409 times for 367 patients. In total Mohsen M El Ramah billed 69,360 services in 228 codes, and Medicare paid $2.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 7,409 | 367 | $0.78 | $5,756 |
| 99458 E&M - Miscellaneous | Office | 7,053 | 767 | $29.72 | $210K |
| 99457 E&M - Miscellaneous | Office | 6,574 | 774 | $37.21 | $245K |
| 99214 Office E&M - Established | Office | 6,385 | 1,245 | $98.62 | $630K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 5,470 | 708 | $43.96 | $240K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,744 | 61 | $0.10 | $498 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,355 | 201 | $0.09 | $208 |
| 96372 Injection Administration | Office | 2,295 | 566 | $11.46 | $26K |
| 99454 E&M - Miscellaneous | Office | 2,023 | 420 | $38.26 | $77K |
| 99308 SNF E&M | Facility | 1,981 | 233 | $58.37 | $116K |
| 99213 Office E&M - Established | Office | 1,671 | 644 | $68.57 | $115K |
| 10005 Other Organ Systems | Office | 1,377 | 352 | $107.63 | $148K |
| 20611 Joint Injection | Office | 1,289 | 340 | $40.74 | $53K |
| 97110 PT Treatment | Office | 1,197 | 51 | $19.40 | $23K |
| 82948 Clinical Chemistry | Office | 1,036 | 432 | $4.93 | $5,108 |
By year: 2022 $2.7M for 61,665 services; 2023 $2.8M for 66,222 services; 2024 $2.7M for 69,360 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82948 Clinical Chemistry | 1,036 | 432 | $4.93 | $5,108 |
| 83036 Blood Count | 991 | 478 | $9.48 | $9,399 |
| 87804 Immunoassay | 151 | 92 | $16.22 | $2,449 |
| 87811 Immunoassay | 144 | 117 | $40.55 | $5,839 |
| 81003 Clinical Chemistry | 143 | 107 | $2.20 | $315 |
| 87635 COVID Specific | 93 | 87 | $50.28 | $4,676 |
| 82947 Clinical Chemistry | 89 | 86 | $3.81 | $339 |
| 87807 Immunoassay | 28 | 27 | $12.84 | $360 |
| 87502 Infectious Agent Detection by DNA/RNA | 28 | 28 | $93.88 | $2,629 |
| 81002 Clinical Chemistry | 26 | 25 | $3.41 | $88.66 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohsen M El Ramah prescribed most often to Medicare patients was Amlodipine Besylate, with 1,685 prescriptions and refills. In total Mohsen M El Ramah wrote 39,950 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,685 | 3,269 | 415 | $11K |
| Atorvastatin Calcium Generic | 1,586 | 3,323 | 423 | $17K |
| Losartan Potassium Generic | 1,361 | 2,634 | 347 | $14K |
| Levothyroxine Sodium Generic | 1,135 | 2,121 | 233 | $13K |
| Metformin Hcl Generic | 1,107 | 2,255 | 289 | $11K |
| Gabapentin Generic | 924 | 1,219 | 261 | $12K |
| Pantoprazole Sodium Generic | 861 | 1,441 | 204 | $15K |
| Furosemide Generic | 819 | 1,245 | 206 | $4,782 |
| Lisinopril Generic | 772 | 1,722 | 208 | $6,327 |
| Tamsulosin Hcl Generic | 761 | 1,352 | 181 | $13K |
| Carvedilol Generic | 743 | 1,335 | 186 | $5,421 |
| Omeprazole Generic | 738 | 1,489 | 207 | $8,136 |
| Eliquis Apixaban | 622 | 765 | 129 | $362K |
| Ozempic Semaglutide | 595 | 700 | 120 | $573K |
| Metoprolol Succinate Generic | 592 | 1,245 | 162 | $10K |
Brand drugs: 7,749 claims; generic drugs: 31,783 claims; opioid claims: 1,330.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohsen M El Ramah $610 ($610 in general payments such as food, travel and fees) from 16 companies. The largest payer was Ascensia Diabetes Care Us Inc. with $96.09.
| Company | Payments | Amount |
|---|---|---|
| Ascensia Diabetes Care Us Inc. | 1 | $96.09 |
| Zimmer Biomet Holdings, Inc. ZBH | 1 | $89.61 |
| Calliditas Therapeutics US Inc. | 3 | $69.34 |
| Shield Therapeutics Inc STX.L | 1 | $60.73 |
| Novo Nordisk Inc NVO | 2 | $45.67 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $35.66 |
| Travere Therapeutics, Inc. TVTX | 11 | $33.83 |
| Lundbeck LLC | 1 | $30.63 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $25.15 |
| Amgen Inc. AMGN | 1 | $24.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.